Published in Malar J on April 15, 2013
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature (2015) 7.02
Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria. Nat Commun (2015) 1.36
Made-to-measure malaria vector control strategies: rational design based on insecticide properties and coverage of blood resources for mosquitoes. Malar J (2014) 0.98
The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models. BMC Med (2015) 0.96
Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine. Malar J (2015) 0.91
Comparative assessment of diverse strategies for malaria vector population control based on measured rates at which mosquitoes utilize targeted resource subsets. Malar J (2014) 0.84
How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector? PLoS Negl Trop Dis (2014) 0.82
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health (2017) 0.81
The Separatrix Algorithm for synthesis and analysis of stochastic simulations with applications in disease modeling. PLoS One (2014) 0.80
The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease. Malar J (2015) 0.75
Fun with maths: exploring implications of mathematical models for malaria eradication. Malar J (2014) 0.75
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol Today (1999) 12.36
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet (2004) 9.24
A global index representing the stability of malaria transmission. Am J Trop Med Hyg (2004) 8.83
A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J (2011) 8.65
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med (2007) 6.80
Insecticide resistance in insect vectors of human disease. Annu Rev Entomol (2000) 6.66
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature (1967) 6.08
The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature (2005) 5.71
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med (1998) 5.41
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg (2001) 5.22
Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg (1999) 5.17
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Quantifying the impact of human mobility on malaria. Science (2012) 4.60
Assessment of insecticide-treated bednet use among children and pregnant women across 15 countries using standardized national surveys. Am J Trop Med Hyg (2009) 4.60
Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Malar J (2011) 4.27
Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg (2007) 4.20
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop (1993) 3.59
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 2. Effects on the malaria vector population. Acta Trop (1991) 3.04
Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies. Trop Med Int Health (2007) 3.02
Integrated urban malaria control: a case study in dar es salaam, Tanzania. Am J Trop Med Hyg (2004) 2.80
Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am J Trop Med Hyg (1955) 2.71
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One (2008) 2.70
The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol (2006) 2.53
Insecticide-treated net (ITN) ownership, usage, and malaria transmission in the highlands of western Kenya. Parasit Vectors (2011) 2.46
The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas. Am J Trop Med Hyg (2000) 2.40
Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg (2006) 2.38
Consistently high estimates for the proportion of human exposure to malaria vector populations occurring indoors in rural Africa. Int J Epidemiol (2013) 2.30
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine (2005) 2.21
Theory of the eradication of malaria. Bull World Health Organ (1956) 2.06
Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology (1977) 2.02
Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia (1999) 2.01
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis (2013) 2.00
Travel risk, malaria importation and malaria transmission in Zanzibar. Sci Rep (2011) 1.97
Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. PLoS Med (2012) 1.83
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar J (2009) 1.72
A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg (2006) 1.70
A malaria transmission-directed model of mosquito life cycle and ecology. Malar J (2011) 1.70
Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J Exp Med (1991) 1.69
The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunol (2009) 1.63
Regulation of infectivity of Plasmodium to the mosquito vector. Adv Parasitol (1996) 1.59
Influence of deltamethrin treatment of bed nets on malaria transmission in the Kou valley, Burkina Faso. Bull World Health Organ (1991) 1.52
Determinants of hanging and use of ITNs in the context of near universal coverage in Zambia. Health Policy Plan (2011) 1.51
Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern. PLoS Pathog (2011) 1.45
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malar J (2010) 1.42
Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology (1993) 1.41
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. PLoS One (2008) 1.38
Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia. Parasit Vectors (2012) 1.38
Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One (2011) 1.32
A biologic basis for integrated malaria control. Am J Trop Med Hyg (2002) 1.30
Barriers to insecticide-treated mosquito net possession 2 years after a mass free distribution campaign in Luangwa District, Zambia. PLoS One (2010) 1.29
Modeling a field trial of the RTS,S/AS02A malaria vaccine. Am J Trop Med Hyg (2006) 1.22
Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings. Am J Trop Med Hyg (2013) 1.22
Simulation of the cost-effectiveness of malaria vaccines. Malar J (2009) 1.13
P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. PLoS One (2012) 1.09
Spatial distribution of bednet coverage under routine distribution through the public health sector in a rural district in Kenya. PLoS One (2011) 1.02
Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Malar J (2012) 1.01
Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Infect Immun (2010) 1.00
Vaccines against malaria - an update. FEBS J (2007) 0.98
A framework for decision-making in integrated vector management to prevent disease. Trop Med Int Health (2007) 0.95
Modeling malaria vaccines. I: New uses for old ideas. Math Biosci (1989) 0.87
Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med (2014) 1.35
Dropout and re-enrollment: implications for epidemiological projections of treatment programs. AIDS (2014) 0.92
Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine. Malar J (2015) 0.91
Age-dependent partnering and the HIV transmission chain: a microsimulation analysis. J R Soc Interface (2013) 0.90
A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns. BMC Syst Biol (2013) 0.77
Influence of high-order nonlinear fluctuations in the multivariate susceptible-infectious-recovered master equation. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.75